
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
BioAgilytix Labs, LLC, a global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development, announced that it signed a formal, worldwide partnership agreement with global contract research organization Clinical Trial and Consulting Services (CTI). The partnership enables both BioAgilytix and CTI to provide their customers with mutually complementary services.






